Specialist Investment Properties PLC:企業の戦略・SWOT・財務情報

◆英語タイトル:Specialist Investment Properties PLC - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C11638
◆発行会社(調査会社):MarketLine
◆発行日:2018年11月
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:サービス
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥23,450見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥46,900見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥70,350見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Specialist Investment Properties PLC – Strategy, SWOT and Corporate Finance Report
Summary

Specialist Investment Properties PLC – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Specialist Investment Properties plc. (SIPP) , formerly known as The Hotel Corporation Plc (Hotel Corp) is a hotel operator and property investment company. The Company invests in homes for adults with learning difficulties requiring support from carers, together with care homes for the elderly and infirm and converted dwellings. It also provides accommodations for young adults/late teens requiring support from social services. SIPP owns children’s homes for those having emotional or behavioural difficulties in Heywood and Bury, Greater Manchester. The Company’s subsidiaries include Secta Limited, Secta Properties Limited and SIPP Holdings Limited. SIPP is headquartered in Douglas, Isle of Man, the UK.

Scope

- Detailed information on Specialist Investment Properties PLC required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Specialist Investment Properties PLC in the form of a SWOT analysis
- An in-depth view of the business model of Specialist Investment Properties PLC including a breakdown and examination of key business segments
- Intelligence on Specialist Investment Properties PLC’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Specialist Investment Properties PLC, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Specialist Investment Properties PLC and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Specialist Investment Properties PLC as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Specialist Investment Properties PLC’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 4
Specialist Investment Properties PLC: Company Overview 6
Specialist Investment Properties PLC: Overview and Key Facts 6
Specialist Investment Properties PLC: Overview 6
Specialist Investment Properties PLC: Key Facts 6
Specialist Investment Properties PLC: Key Employees 7
Specialist Investment Properties PLC: Major Products and Services 8
Specialist Investment Properties PLC: Company History 9
Specialist Investment Properties PLC: Locations and Subsidiaries 11
Specialist Investment Properties PLC: Key Competitors 12
Specialist Investment Properties PLC: Company Analysis 13
Specialist Investment Properties PLC: Business Description 13
Specialist Investment Properties PLC: SWOT Analysis 14
Specialist Investment Properties PLC: SWOT Overview 14
Specialist Investment Properties PLC: Strengths 14
Specialist Investment Properties PLC: Weaknesses 14
Specialist Investment Properties PLC: Opportunities 15
Specialist Investment Properties PLC: Threats 15
Appendix 17
Contact Us 17
Methodology 17
About MarketLine 18

List of Tables
Table 1: Specialist Investment Properties PLC: Key Facts
Table 2: Specialist Investment Properties PLC: Key Employees
Table 3: Specialist Investment Properties PLC: Company History
Table 4: Specialist Investment Properties PLC: Locations and Subsidiaries
Table 5: Specialist Investment Properties PLC: Key Competitors



★海外企業調査レポート[Specialist Investment Properties PLC:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • T2 Biosystems Inc (TTOO):医療機器:M&Aディール及び事業提携情報
    Summary T2 Biosystems Inc (T2 Biosystems) is a provider of clinical diagnostic products in the field of in vitro diagnostics. The company’s T2 magnetic resonance technology allows direct detection in complex samples such as whole blood, serum, plasma, sputum and urine. It offers T2HemoStat panel, T2 …
  • Cenovus Energy Inc (CVE):企業の財務・戦略的SWOT分析
    Cenovus Energy Inc (CVE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Landauer Inc (LDR):企業の財務・戦略的SWOT分析
    Summary Landauer Inc (Landauer), a subsidiary of Fortive Corp, is a medical device company that manufactures and distributes integrated radiation safety products. The company provides professional medical physics, occupational radiation monitoring, and medical products. Its products include dosimete …
  • Albumedix AS-製薬・医療分野:企業M&A・提携分析
    Summary Albumedix A/S (Albumedix), a subsidiary of Novozymes A/S, is a developer of albumin-based products and technologies for advanced drug and vaccine formulation, extended drug half-life and improved drug delivery. Its product Recombumin is a recombinant human albumin used in the manufacture of …
  • Teikoku Seiyaku Co Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Teikoku Seiyaku Co Ltd (Teikoku Seiyaku) is a medical device company that develops, manufactures and distributes medicated and medically related supplies. The company offers Chinese medicine, other medicinal products, quasi-drugs, cosmetics, hot sensation plaster, transdermal indomethacin me …
  • Fortitech Inc.:戦略・SWOT・企業財務分析
    Fortitech Inc. - Strategy, SWOT and Corporate Finance Report Summary Fortitech Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Ascom Holding AG:企業のM&A・事業提携・投資動向
    Ascom Holding AG - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Ascom Holding AG Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), dives …
  • Heska Corp (HSKA):企業の財務・戦略的SWOT分析
    Heska Corp (HSKA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Caisse de depot et placement du Quebec:企業の戦略・SWOT・財務分析
    Caisse de depot et placement du Quebec - Strategy, SWOT and Corporate Finance Report Summary Caisse de depot et placement du Quebec - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT ana …
  • Taiwan Semiconductor Manufacturing Company Limited:企業の戦略・SWOT・財務分析
    Taiwan Semiconductor Manufacturing Company Limited - Strategy, SWOT and Corporate Finance Report Summary Taiwan Semiconductor Manufacturing Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's struct …
  • Teva Pharmaceuticals USA Inc:企業のM&A・事業提携・投資動向
    Teva Pharmaceuticals USA Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Teva Pharmaceuticals USA Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and a …
  • Biosense Webster Inc:企業の製品パイプライン分析
    Summary Biosense Webster Inc (Biosense Webster), a subsidiary of Johnson & Johnson, is a medical device company that designs, manufactures and markets cardiac arrhythmias products. The company’s products include ablation catheters, diagnostic catheters and access, ultrasound catheters and 3D cardiac …
  • Weifa ASA (WEIFA)-石油・ガス分野:企業M&A・提携分析
    Summary Weifa ASA (Weifa), formerly Aqualis ASA, is a pharmaceutical company that conducts the research and development, manufacture, distribution and sales of pharmaceutical products, lifestyle products and solutions. The company has over the counter (OTC) pharmaceutical market in Norway offering p …
  • Memorial Health System:企業の戦略的SWOT分析
    Memorial Health System - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Dai Nippon Printing Co Ltd (7912):企業の財務・戦略的SWOT分析
    Dai Nippon Printing Co Ltd (7912) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • CiToxLAB Group:製薬・医療:M&Aディール及び事業提携情報
    Summary CiToxLab Group (CiToxLab) is a contract research organization that provides preclinical and specialty services. The company provides toxicology and safety pharmacology, biomarkers, pharmacokinetics, immunology services, surgical models and medical device implantation, animal efficacy models, …
  • Rosenergoatom Concern JSC:企業の戦略的SWOT分析
    Rosenergoatom Concern JSC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Cooperativa Muratori & Cementisti C.M.C di Ravenna:企業の戦略・SWOT・財務分析
    Cooperativa Muratori & Cementisti C.M.C di Ravenna - Strategy, SWOT and Corporate Finance Report Summary Cooperativa Muratori & Cementisti C.M.C di Ravenna - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's struct …
  • Cleveland BioLabs Inc (CBLI):企業の財務・戦略的SWOT分析
    Summary Cleveland BioLabs Inc (Cleveland) is a biopharmaceutical company that develops and commercializes drugs to treat cancer, orphan indications and protect healthy tissues from radiation and chemotherapy. The company’s product includes entolimod, a recombinant protein that acts as an agonist of …
  • NovoCure Ltd (NVCR):製薬・医療:M&Aディール及び事業提携情報
    Summary NovoCure Ltd (NovoCure) is an drug company that offers development and commercialization of novel therapies for tumor treating fields. The company’s pipeline products find application in cancer indications such as malignant melanoma, hepatocellular carcinoma, ovarian cancer, breast cancer an …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆